Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Equity (2016 - 2025)

Regenxbio (RGNX) has 11 years of Return on Equity data on record, last reported at 1.47% in Q4 2025.

  • For Q4 2025, Return on Equity fell 66.0% year-over-year to 1.47%; the TTM value through Dec 2025 reached 1.47%, down 66.0%, while the annual FY2025 figure was 1.07%, 107.0% down from the prior year.
  • Return on Equity reached 1.47% in Q4 2025 per RGNX's latest filing, down from 0.95% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.21% in Q4 2021 and bottomed at 1.47% in Q4 2025.
  • Average Return on Equity over 5 years is 0.51%, with a median of 0.61% recorded in 2023.
  • Peak YoY movement for Return on Equity: skyrocketed 56bps in 2022, then plummeted -80bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.21% in 2021, then tumbled by -349bps to 0.52% in 2022, then tumbled by -51bps to 0.78% in 2023, then fell by -4bps to 0.81% in 2024, then crashed by -81bps to 1.47% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 1.47% in Q4 2025, 0.95% in Q3 2025, and 0.72% in Q2 2025.